J H Reyna-Verdugo, J R Chávez-Méndez, J M Cornejo-Bravo, J Isaías de León-Ramírez, V A Reyes-Villegas, A Serrano-Medina, N A Castillo-Martínez
{"title":"Accuracy of a fluorescent dye-qPCR for diagnosis of pulmonary TB in HIV-associated adults.","authors":"J H Reyna-Verdugo, J R Chávez-Méndez, J M Cornejo-Bravo, J Isaías de León-Ramírez, V A Reyes-Villegas, A Serrano-Medina, N A Castillo-Martínez","doi":"10.5588/ijtld.25.0693","DOIUrl":null,"url":null,"abstract":"<p><p><sec><title>BACKGROUND</title>TB remains a major public health concern in Baja California, Mexico, where access to molecular diagnostics is limited.</sec><sec><title>METHODS</title>We evaluated the diagnostic performance of a fluorescent dye-based real-time quantitative PCR (SYBR-qPCR) assay targeting the IS6110 sequence for the detection of pulmonary TB (PTB). This was a cross-sectional diagnostic accuracy study conducted using sputum samples from 113 adults with clinical suspicion of PTB. Samples were analysed by acid-fast bacilli (AFB) smear microscopy, Löwenstein-Jensen culture as the reference standard, and SYBR-qPCR. Diagnostic performance was assessed using sensitivity, specificity, predictive values, and likelihood ratios. Receiver operating characteristic analysis was used to determine the optimal cycle threshold (Ct) cut-off.</sec><sec><title>RESULTS</title>SYBR-qPCR showed a sensitivity of 98.3% and a specificity of 92.5%. Sensitivity remained high among HIV-positive participants (96.6%), although specificity was lower (78.6%). In HIV-negative participants, both sensitivity and specificity exceeded 97%. The combination of SYBR-qPCR and AFB smear microscopy improved sensitivity (100%), and mean Ct values did not differ by HIV status.</sec><sec><title>CONCLUSION</title>SYBR-qPCR demonstrated consistent diagnostic performance across HIV strata, supporting its feasibility as a low-cost molecular tool for TB detection in resource-limited settings.</sec>.</p>","PeriodicalId":520801,"journal":{"name":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease","volume":"30 7","pages":"309-315"},"PeriodicalIF":3.1000,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5588/ijtld.25.0693","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUNDTB remains a major public health concern in Baja California, Mexico, where access to molecular diagnostics is limited.METHODSWe evaluated the diagnostic performance of a fluorescent dye-based real-time quantitative PCR (SYBR-qPCR) assay targeting the IS6110 sequence for the detection of pulmonary TB (PTB). This was a cross-sectional diagnostic accuracy study conducted using sputum samples from 113 adults with clinical suspicion of PTB. Samples were analysed by acid-fast bacilli (AFB) smear microscopy, Löwenstein-Jensen culture as the reference standard, and SYBR-qPCR. Diagnostic performance was assessed using sensitivity, specificity, predictive values, and likelihood ratios. Receiver operating characteristic analysis was used to determine the optimal cycle threshold (Ct) cut-off.RESULTSSYBR-qPCR showed a sensitivity of 98.3% and a specificity of 92.5%. Sensitivity remained high among HIV-positive participants (96.6%), although specificity was lower (78.6%). In HIV-negative participants, both sensitivity and specificity exceeded 97%. The combination of SYBR-qPCR and AFB smear microscopy improved sensitivity (100%), and mean Ct values did not differ by HIV status.CONCLUSIONSYBR-qPCR demonstrated consistent diagnostic performance across HIV strata, supporting its feasibility as a low-cost molecular tool for TB detection in resource-limited settings..